ArticleBiomedical optics express2025
Diode-based photoacoustic imaging for monitoring therapeutic response in rheumatoid arthritis.
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeted Near-Infrared Photoacoustic Probes for Dual-Channel Cartilage and Bone Imaging.Angewandte Chemie (International ed. in English) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the application of diode-based photoacoustic imaging (PAI) for monitoring treatment responses in patients with rheumatoid arthritis (RA). Diode-based PAI provides a non-invasive and real-time assessment of joint inflammation by visualizing changes in vascularization. We conducted the analysis based on physician-diagnosed RA patients and compared the PAI results between osteoarthritis, psoriatic arthritis, and lupus-induced arthritis. Our findings demonstrate that PAI effectively captures synovitis and vascularity and can discriminate RA from other types of arthritis as well as from healthy subjects, which is of great value for physicians in improving disease management. Moreover, we could demonstrate that PAI can detect early changes of inflammation in RA joints after treatment, correlating with improvements in clinical exams. The study highlights LED-based PAI as a promising tool for enhancing treatment monitoring and personalizing therapeutic approaches in RA management. Further research is recommended to validate these findings across larger populations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.